A Phase IIIB, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Dysport Using 2 mf Dilution in Adults with Cervical Dystonia

ID Number 13-0722

Principal Investigator(s)
Winona Tse

Department(s) or Division(s)
Neurology

Description

The purpose of this research study is to evaluate the safety and effectiveness of a botulinum toxin for treating cervical dystonia. This study will look at botulinum toxin as a 2 milliliter (about ½ teaspoon) injection compared to a placebo. The Parkinson and Movement Disorder Center at Mount Sinai is looking for individuals over the age of 18 with cervical dystonia. 



Contact Information
Joan Bratton
(212) 241-0279
movementdisorders@mountsinai.org

Recruiting Patients: Yes